Paramount Group Valuation
Is PGRE undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PGRE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PGRE ($4.7) is trading above our estimate of fair value ($2.03)
Significantly Below Fair Value: PGRE is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PGRE?
Key metric: As PGRE is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is PGRE's PS Ratio? | |
|---|---|
| PS Ratio | 1.8x |
| Sales | US$553.64m |
| Market Cap | US$1.15b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 9.5x |
| Enterprise Value/EBITDA | 29.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PGRE's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.8x | ||
PDM Piedmont Office Realty Trust | 2x | 0.8% | US$1.2b |
BDN Brandywine Realty Trust | 2.9x | 10.2% | US$900.5m |
JBGS JBG SMITH Properties | 2.2x | -11.2% | US$1.5b |
DEA Easterly Government Properties | 4.2x | 8.9% | US$1.4b |
PGRE Paramount Group | 1.8x | 4.4% | US$1.1b |
Price-To-Sales vs Peers: PGRE is good value based on its Price-To-Sales Ratio (1.8x) compared to the peer average (2.8x).
Price to Sales Ratio vs Industry
How does PGRE's PS Ratio compare vs other companies in the US Office REITs Industry?
Price-To-Sales vs Industry: PGRE is good value based on its Price-To-Sales Ratio (1.8x) compared to the US Office REITs industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is PGRE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.8x |
| Fair PS Ratio | 2.2x |
Price-To-Sales vs Fair Ratio: PGRE is good value based on its Price-To-Sales Ratio (1.8x) compared to the estimated Fair Price-To-Sales Ratio (2.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$4.70 | US$5.38 +14.4% | 12.1% | US$6.00 | US$4.50 | n/a | 4 |
| Nov ’25 | US$4.81 | US$5.13 +6.5% | 17.4% | US$6.00 | US$4.00 | n/a | 4 |
| Oct ’25 | US$4.89 | US$4.88 -0.3% | 15.2% | US$6.00 | US$4.00 | n/a | 4 |
| Sep ’25 | US$5.05 | US$4.60 -8.9% | 18.7% | US$6.00 | US$3.50 | n/a | 5 |
| Aug ’25 | US$5.06 | US$4.60 -9.1% | 18.7% | US$6.00 | US$3.50 | n/a | 5 |
| Jul ’25 | US$4.59 | US$4.60 +0.2% | 18.7% | US$6.00 | US$3.50 | n/a | 5 |
| Jun ’25 | US$4.55 | US$4.60 +1.1% | 18.7% | US$6.00 | US$3.50 | n/a | 5 |
| May ’25 | US$4.62 | US$4.60 -0.4% | 18.7% | US$6.00 | US$3.50 | n/a | 5 |
| Apr ’25 | US$4.55 | US$4.60 +1.1% | 18.7% | US$6.00 | US$3.50 | n/a | 5 |
| Mar ’25 | US$4.43 | US$4.64 +4.7% | 18.5% | US$6.00 | US$3.50 | n/a | 5 |
| Feb ’25 | US$4.74 | US$4.64 -2.1% | 18.5% | US$6.00 | US$3.50 | n/a | 5 |
| Jan ’25 | US$5.17 | US$4.64 -10.3% | 18.5% | US$6.00 | US$3.50 | n/a | 5 |
| Dec ’24 | US$5.09 | US$4.40 -13.6% | 19.6% | US$6.00 | US$3.50 | n/a | 5 |
| Nov ’24 | US$4.26 | US$4.60 +8.0% | 18.7% | US$6.00 | US$3.50 | US$4.81 | 5 |
| Oct ’24 | US$4.62 | US$5.00 +8.2% | 22.8% | US$7.00 | US$3.50 | US$4.89 | 5 |
| Sep ’24 | US$5.13 | US$5.00 -2.5% | 22.8% | US$7.00 | US$3.50 | US$5.05 | 5 |
| Aug ’24 | US$4.85 | US$4.90 +1.0% | 26.1% | US$7.00 | US$3.00 | US$5.06 | 5 |
| Jul ’24 | US$4.43 | US$4.70 +6.1% | 28.2% | US$7.00 | US$3.00 | US$4.59 | 5 |
| Jun ’24 | US$4.26 | US$4.92 +15.4% | 20.7% | US$7.00 | US$4.00 | US$4.55 | 6 |
| May ’24 | US$4.25 | US$5.17 +21.6% | 18.2% | US$7.00 | US$4.00 | US$4.62 | 6 |
| Apr ’24 | US$4.56 | US$5.17 +13.3% | 18.2% | US$7.00 | US$4.00 | US$4.55 | 6 |
| Mar ’24 | US$5.20 | US$6.33 +21.8% | 15.6% | US$8.00 | US$5.00 | US$4.43 | 6 |
| Feb ’24 | US$6.44 | US$6.50 +0.9% | 15.4% | US$8.00 | US$5.00 | US$4.74 | 5 |
| Jan ’24 | US$5.94 | US$6.70 +12.8% | 17.4% | US$8.00 | US$5.00 | US$5.17 | 5 |
| Dec ’23 | US$6.28 | US$8.17 +30.0% | 39.5% | US$15.00 | US$5.00 | US$5.09 | 6 |
| Nov ’23 | US$6.41 | US$8.67 +35.2% | 35.0% | US$15.00 | US$5.00 | US$4.26 | 6 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Innovative Industrial Properties
US$2.9b
A self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities.
IIPR
US$104.75
7D
-2.8%
1Y
30.0%
Park Hotels & Resorts
US$3.0b
Park is one of the largest publicly traded lodging REITs with a diverse portfolio of market-leading hotels and resorts with significant underlying real estate value.
PK
US$14.28
7D
-4.6%
1Y
-1.9%
Boardwalk Real Estate Investment Trust
CA$3.7b
Boardwalk REIT strives to be Canada's friendliest community provider and is a leading owner/operator of multi-family rental communities.
BOWF.F
CA$49.23
7D
-2.5%
1Y
1.7%